Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Diaz Beya, M.
~ 100  Ergebnisse:
Personensuche X
?
1

P523: MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY IN FLT3 MUTAT..:

De La Fuente, A. ; Diaz Beya, M. ; Beneit, P....
HemaSphere.  6 (2022)  - p. 422-423 , 2022
Link: https://doi.org/10.1097/..
 
?
2

Topic: AS07-Singular Entities/Subtypes/AS07e-Chronic myelom..:

Castaño-Díez, S. ; Pomares, H. ; Jiménez-Vicente, C....
Leukemia Research.  128 (2023)  - p. 107255 , 2023
Link: https://doi.org/10.1016/..
 
?
3

P788: FACTORS DRIVING TREATMENT DECISION IN PATIENTS WITH I..:

Díez-Campelo, M. ; Hernandez-Donoso, L. ; Sasse, E....
HemaSphere.  6 (2022)  - p. 683-684 , 2022
Link: https://doi.org/10.1097/..
 
?
4

Response to azacitidine in patients with chronic myelomonoc..:

Triguero, A. ; Xicoy, B. ; Zamora, L....
Leukemia Research.  116 (2022)  - p. 106836 , 2022
Link: https://doi.org/10.1016/..
 
?
5

P569: GILTERITINIB AND QUIZARTINIB IN RELAPSED/REFRACTORY (..:

Quintela, D. ; Morgades, M. ; Serrano, A....
HemaSphere.  6 (2022)  - p. 468-469 , 2022
Link: https://doi.org/10.1097/..
 
?
6

Response to Azacitidine in a Series of 94 Patients with Chr..:

Triguero, A. ; Xicoy, B. ; Jiménez, M.J....
Leukemia Research.  55 (2017)  - p. S74-S75 , 2017
Link: https://doi.org/10.1016/..
 
?
7

Inhibition of serotonin receptor type 1 in acute myeloid le..:

Etxabe, A ; Lara-Castillo, M C ; Cornet-Masana, J M...
Leukemia.  31 (2017)  11 - p. 2288-2302 , 2017
Link: https://doi.org/10.1038/..
 
?
8

The expression level of BAALC-associated microRNA miR-3151 ..:

Díaz-Beyá, M ; Brunet, S ; Nomdedéu, J...
Blood Cancer Journal.  5 (2015)  10 - p. e352-e352 , 2015
Link: https://doi.org/10.1038/..
 
?
9

BAALC-associated miR-3151 is an Independent Prognostic Fact..:

Díaz-Beyá, M. ; Navarro, A. ; Pratcorona, M....
Clinical Lymphoma Myeloma and Leukemia.  14 (2014)  - p. S122-S123 , 2014
Link: https://doi.org/10.1016/..
 
?
10

P523: MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY IN FLT3 MUTAT..:

A. De La Fuente ; M. Diaz Beya ; P. Beneit...
http://journals.lww.com/10.1097/01.HS9.0000844980.63062.91.  , 2022
Link: https://doi.org/10.1097/..
 
?
11

MIR135A1 (microRNA 135a-1):

Navarro, A ; Díaz-Beyá, M ; Monzó, M
Atlas of Genetics and Cytogenetics in Oncology and Haematology.  , 2014
Link: http://hdl.handle.net/20..
 
?
12

The expression level of BAALC-associated microRNA miR-3151 ..:

Díaz-Beyá, M ; Pedro Olive, Carme ; Esteve, J
Blood Cancer Journal. 2015 Oct 2;5:e352.  ,
Link: http://hdl.handle.net/10..
 
?
13

Germ line variants in patients with acute myeloid leukemia ..:

Guijarro, Francesca ; López-Guerra, Monica ; Morata, Jordi...
Blood Advances.  7 (2023)  19 - p. 5799-5811 , 2023
Link: https://doi.org/10.1182/..
 
?
14

European LeukemiaNet 2017 risk stratification for acute mye..:

Bataller, Alex ; Garrido, Ana ; Guijarro, Francesca...
Blood Advances.  6 (2022)  4 - p. 1193-1206 , 2022
Link: https://doi.org/10.1182/..
 
?
15

A Systems Biology- and Machine Learning-Based Study to Unra..:

Díaz-Beyá, Marina ; García-Fortes, María ; Valls, Raquel...
BioMedInformatics.  2 (2022)  3 - p. 375-397 , 2022
Link: https://doi.org/10.3390/..
 
1-15